Rituxan Effective as Maintenance Therapy for Difficult-to-treat SLE Patients, Study Says
Rituxan (rituximab) can be effective as maintenance therapy for difficult-to-treat patients with systemic lupus erythematosus, allowing them to cut their use of corticosteroids and immunosuppressive agents, a new study says. However, relapses continue to occur frequently, mostly in patients with active joint disease. The study, “Rituximab…